Drew Moghanaki, Professor, Chief of Thoracic Oncology at UCLA Department of Radiation Oncology, recently shared on X/Twitter:
“A critical report from Amsterdam demonstrates how often drug-related pneumonitis can be misdiagnosed in patients receiving thoracic radiation therapy. When it occurs, it can lead to premature termination of life-prolonging checkpoint inhibitors.
Access to radiation therapy treatment plans can make all the difference when trying to determine whether radiographic abnormalities on surveillance CT scans represent a harbinger of symptomatic drug-induced pneumonitis versus just an asymptomatic remnant of beam tracks.”
Source: Drew Moghanaki/X